TransMedics Highlights Presentation Of Heart, Lung Device Data At Int’l. Society Of Heart, Lung Transplatation Meeting Apr. 28, 29
TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that